153 related articles for article (PubMed ID: 9971784)
1. Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias.
Bies J; Nazarov V; Wolff L
J Virol; 1999 Mar; 73(3):2038-44. PubMed ID: 9971784
[TBL] [Abstract][Full Text] [Related]
2. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.
Mukhopadhyaya R; Wolff L
J Virol; 1992 Oct; 66(10):6035-44. PubMed ID: 1527851
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
4. MuLV-insertional mutagenesis of c-myb and Mml1 in a murine model for promonocytic leukemia.
Bies J; Koller R; Hoffman B; Amanullah A; Mock B; Wolff L
Leukemia; 1997 Apr; 11 Suppl 3():247-50. PubMed ID: 9209355
[TBL] [Abstract][Full Text] [Related]
5. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.
Wolff L; Koller R; Davidson W
J Virol; 1991 Jul; 65(7):3607-16. PubMed ID: 1645785
[TBL] [Abstract][Full Text] [Related]
7. Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma.
Jiang W; Kanter MR; Dunkel I; Ramsay RG; Beemon KL; Hayward WS
J Virol; 1997 Sep; 71(9):6526-33. PubMed ID: 9261372
[TBL] [Abstract][Full Text] [Related]
8. Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia.
Haeri M; Li Y; Li Y; Li Q; Spaner DE; Ben-David Y
Int J Oncol; 2013 Jul; 43(1):169-76. PubMed ID: 23677281
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.
Press RD; Reddy EP; Ewert DL
Mol Cell Biol; 1994 Apr; 14(4):2278-90. PubMed ID: 8139533
[TBL] [Abstract][Full Text] [Related]
10. Alteration of proteolytic processing of c-Myb as a consequence of its truncation in murine myeloid leukemia.
Bies J; Nazarov V; Wolff L
Leukemia; 1999 Apr; 13 Suppl 1():S116-7. PubMed ID: 10232384
[No Abstract] [Full Text] [Related]
11. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
[TBL] [Abstract][Full Text] [Related]
12. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
Bies J; Mukhopadhyaya R; Pierce J; Wolff L
Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
[TBL] [Abstract][Full Text] [Related]
13. Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells.
Feiková S; Wolff L; Bies J
Neoplasma; 2000; 47(4):212-8. PubMed ID: 11043824
[TBL] [Abstract][Full Text] [Related]
14. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain.
Miglarese MR; Richardson AF; Aziz N; Bender TP
J Biol Chem; 1996 Sep; 271(37):22697-705. PubMed ID: 8798443
[TBL] [Abstract][Full Text] [Related]
16. Retroviral insertional mutagenesis in murine promonocytic leukemias: c-myb and Mml1.
Wolff L; Koller R; Bies J; Nazarov V; Hoffman B; Amanullah A; Krall M; Mock B
Curr Top Microbiol Immunol; 1996; 211():191-9. PubMed ID: 8585950
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
18. Myb-induced transformation.
Wolff L
Crit Rev Oncog; 1996; 7(3-4):245-60. PubMed ID: 9258605
[TBL] [Abstract][Full Text] [Related]
19. Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration.
Denicourt C; Edouard E; Rassart E
J Virol; 1999 May; 73(5):4439-42. PubMed ID: 10196342
[TBL] [Abstract][Full Text] [Related]
20. Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.
Le Rouzic E; Perbal B
J Virol; 1996 Nov; 70(11):7414-23. PubMed ID: 8892859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
